Caballa Susan 4
4 · ALIMERA SCIENCES INC · Filed Feb 14, 2012
Insider Transaction Report
Form 4
Caballa Susan
SEE REMARKS
Transactions
- Award
Employee Stock Option (Right to Buy)
2012-02-10+60,000→ 60,000 totalExercise: $1.65Exp: 2022-02-09→ Common Stock (60,000 underlying) - Award
Employee Stock Option (Right to Buy)
2012-02-10+25,000→ 25,000 totalExercise: $1.65→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]This option shall vest in forty-eight equal monthly installments beginning on March 10, 2012.
- [F2]This option shall vest in full upon receipt by the Issuer, on or prior to August 9, 2013, of approval from the U.S. Food and Drug Administration of the Issuer's New Drug Application for ILUVIEN (the "Vesting Event").
- [F3]This option shall expire on February 9, 2022, if the Vesting Event occurs. If the Vesting Event does not occur, then the option will expire on August 10, 2013.